An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy

Subconjunctival fibrosis (SCF) is a common and refractory eye disease that is a serious threat to vision. The severe side effects of existing drugs and low drug bioavailability due to the ocular barrier are major challenges in SCF treatment. Hence, there is an urgent need to explore safer and more e...

Full description

Saved in:
Bibliographic Details
Main Authors: Xue Sun, Haohao Cui, Jingfan Li, Boyuan An, Ruixing Liu, Zhihua Guo, Dandan Chu, Xingchen Geng, Bingbing Cui, Lei Zhu, Jingguo Li, Zhanrong Li
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006424004411
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533308254552064
author Xue Sun
Haohao Cui
Jingfan Li
Boyuan An
Ruixing Liu
Zhihua Guo
Dandan Chu
Xingchen Geng
Bingbing Cui
Lei Zhu
Jingguo Li
Zhanrong Li
author_facet Xue Sun
Haohao Cui
Jingfan Li
Boyuan An
Ruixing Liu
Zhihua Guo
Dandan Chu
Xingchen Geng
Bingbing Cui
Lei Zhu
Jingguo Li
Zhanrong Li
author_sort Xue Sun
collection DOAJ
description Subconjunctival fibrosis (SCF) is a common and refractory eye disease that is a serious threat to vision. The severe side effects of existing drugs and low drug bioavailability due to the ocular barrier are major challenges in SCF treatment. Hence, there is an urgent need to explore safer and more effective strategies for administering anti-SCF drugs. Herein, an injectable and adaptable hydrogel system containing the antifibrotic drug rapamycin was fabricated to address this complex need. This system possesses moderate mechanical properties, self-healing and shape-adaptive capabilities, injectability, and biosafety. It is designed to promote autophagy by modulating the PI3K/AKT/mTOR/WIPI2 pathway, thereby inhibiting SCF. In vivo experiments utilizing a rat subconjunctival injury model indicated that in situ administration of this hydrogel system effectively inhibited SCF. This system constitutes a promising method for promoting autophagy to protect against SCF, which will foster its widespread application for other fibrotic diseases.
format Article
id doaj-art-6a85c3844308497b88015998cb96e734
institution Kabale University
issn 2590-0064
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj-art-6a85c3844308497b88015998cb96e7342025-01-17T04:52:01ZengElsevierMaterials Today Bio2590-00642025-02-0130101380An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagyXue Sun0Haohao Cui1Jingfan Li2Boyuan An3Ruixing Liu4Zhihua Guo5Dandan Chu6Xingchen Geng7Bingbing Cui8Lei Zhu9Jingguo Li10Zhanrong Li11Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaCorresponding author.; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaCorresponding author.; Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, ChinaSubconjunctival fibrosis (SCF) is a common and refractory eye disease that is a serious threat to vision. The severe side effects of existing drugs and low drug bioavailability due to the ocular barrier are major challenges in SCF treatment. Hence, there is an urgent need to explore safer and more effective strategies for administering anti-SCF drugs. Herein, an injectable and adaptable hydrogel system containing the antifibrotic drug rapamycin was fabricated to address this complex need. This system possesses moderate mechanical properties, self-healing and shape-adaptive capabilities, injectability, and biosafety. It is designed to promote autophagy by modulating the PI3K/AKT/mTOR/WIPI2 pathway, thereby inhibiting SCF. In vivo experiments utilizing a rat subconjunctival injury model indicated that in situ administration of this hydrogel system effectively inhibited SCF. This system constitutes a promising method for promoting autophagy to protect against SCF, which will foster its widespread application for other fibrotic diseases.http://www.sciencedirect.com/science/article/pii/S2590006424004411Subconjunctival fibrosisRapamycinIn situ hydrogelAutophagy
spellingShingle Xue Sun
Haohao Cui
Jingfan Li
Boyuan An
Ruixing Liu
Zhihua Guo
Dandan Chu
Xingchen Geng
Bingbing Cui
Lei Zhu
Jingguo Li
Zhanrong Li
An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy
Materials Today Bio
Subconjunctival fibrosis
Rapamycin
In situ hydrogel
Autophagy
title An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy
title_full An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy
title_fullStr An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy
title_full_unstemmed An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy
title_short An injectable shape-adaptive hydrogel system for subconjunctival injuries: In situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy
title_sort injectable shape adaptive hydrogel system for subconjunctival injuries in situ and permanently releases rapamycin to prevent fibrosis via promoting autophagy
topic Subconjunctival fibrosis
Rapamycin
In situ hydrogel
Autophagy
url http://www.sciencedirect.com/science/article/pii/S2590006424004411
work_keys_str_mv AT xuesun aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT haohaocui aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT jingfanli aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT boyuanan aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT ruixingliu aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT zhihuaguo aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT dandanchu aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT xingchengeng aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT bingbingcui aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT leizhu aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT jingguoli aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT zhanrongli aninjectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT xuesun injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT haohaocui injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT jingfanli injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT boyuanan injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT ruixingliu injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT zhihuaguo injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT dandanchu injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT xingchengeng injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT bingbingcui injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT leizhu injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT jingguoli injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy
AT zhanrongli injectableshapeadaptivehydrogelsystemforsubconjunctivalinjuriesinsituandpermanentlyreleasesrapamycintopreventfibrosisviapromotingautophagy